Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

388 ARTÍCULOS , VIENDO DEL 16 AL 30

Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial

Wilcock GK, Gauthier S, Frisoni GB, Jia J, Hardlund JH, Moebius HJ, Bentham P, Kook KA, Schelter BO, Wischik DJ, Davis CS, Staff RT, Vuksanovic V, Ahearn T, Bracoud L, Shamsi K, Marek K, Seibyl J, Riedel G, Storey JMD, Harrington CR, Wischik CM.

J Alzheimers Dis. 2018;61(1):435-457. doi: 10.3233/JAD-170560.

Effects of Physical Exercise on Alzheimer's Disease Biomarkers: A Systematic Review of Intervention Studies

Frederiksen KS, Gjerum L, Waldemar G, Hasselbalch SG.

J Alzheimers Dis. 2018;61(1):359-372. doi: 10.3233/JAD-170567.

Longitudinal Neuroimaging Analysis in Mild-Moderate Alzheimer's Disease Patients Treated with Plasma Exchange with 5% Human Albumin

Cuberas-Borrós G, Roca I, Boada M, Tárraga L, Hernández I, Buendia M, Rubio L, Torres G, Bittini Á, Guzmán-de-Villoria JA, Pujadas F, Torres M, Núñez L, Castell J, Páez A.

J Alzheimers Dis. 2018;61(1):321-332. doi: 10.3233/JAD-170693.

Translational Research in Alzheimer's and Prion Diseases

Di Fede G, Giaccone G, Salmona M, Tagliavini F.

J Alzheimers Dis. 2018;62(3):1247-1259. doi: 10.3233/JAD-170770.

Phenolic Acids Exert Anticholinesterase and Cognition-Improving Effects

Szwajgier D, Baranowska-Wojcik E, Borowiec K.

Curr Alzheimer Res. 2018;15(6):531-543. doi: 10.2174/1567205014666171128102557.

Alzheimer: A Decade of Drug Design. Why Molecular Topology can be an Extra Edge?

Zanni R, Garcia-Domenech R, Galvez-Llompart M, Galvez J.

Curr Neuropharmacol. 2018;16(6):849-864. doi: 10.2174/1570159X15666171129102042.

Natural Product Formulations for the Prevention and Treatment of Alzheimer's disease: A Patent Review

Koynova R, Tenchov B.

Recent Pat Drug Deliv Formul. 2018;12(1):23-39. doi: 10.2174/1872211312666171207152326.

The Rationale and Design of the Reducing Pathology in Alzheimer's Disease through Angiotensin TaRgeting (RADAR) Trial

Kehoe PG, Blair PS, Howden B, Thomas DL, Malone IB, Horwood J, Clement C, Selman LE, Baber H, Lane A, Coulthard E, Passmore AP, Fox NC, Wilkinson IB, Ben-Shlomo Y.

J Alzheimers Dis. 2018;61(2):803-814. doi: 10.3233/JAD-170101.

While I Still Remember: 30 Years of Alzheimer's Disease Research

Shea TB.

J Alzheimers Dis. 2018;62(3):1049-1057. doi: 10.3233/JAD-170724.

Modeling Prion-Like Processing of Tau Protein in Alzheimer's Disease for Pharmaceutical Development

Wischik CM, Schelter BO, Wischik DJ, Storey JMD, Harrington CR.

J Alzheimers Dis. 2018;62(3):1287-1303. doi: 10.3233/JAD-170727.

Nicotinamide adenine dinucleotide and its related precursors for the treatment of Alzheimer's disease

Braidy N, Grant R, Sachdev PS.

Curr Opin Psychiatry. 2018 Mar;31(2):160-166. doi: 10.1097/YCO.0000000000000394.

Nanomedicine Strategies for Sustained, Controlled and Targeted Treatment of Alzheimer's Disease

Ma TJ, Gao J, Liu Y, Zhuang JH, Yin C, Li P, Mao L, Xu J, Xu YX, Li YP, Zhao ZX, Yin Y.

Mini Rev Med Chem. 2018;18(12):1035-1046. doi: 10.2174/1389557518666171215150024.

Toward a Rational Design to Regulate β-Amyloid Fibrillation for Alzheimer's Disease Treatment

Han X, He G.

ACS Chem Neurosci. 2018 Feb 21;9(2):198-210. doi: 10.1021/acschemneuro.7b00477. Epub 2018 Jan 3.

Rationale and Design of the Mechanistic Potential of Antihypertensives in Preclinical Alzheimer's (HEART) Trial

Wharton W, Goldstein FC, Tansey MG, Brown AL, Tharwani SD, Verble DD, Cintron A, Kehoe PG.

J Alzheimers Dis. 2018;61(2):815-824. doi: 10.3233/JAD-161198.

Memantine for the Treatment of Dementia: A Review on its Current and Future Applications

Folch J, Busquets O, Ettcheto M, Sánchez-López E, Castro-Torres RD, Verdaguer E, Garcia ML, Olloquequi J, Casadesús G, Beas-Zarate C, Pelegri C, Vilaplana J, Auladell C, Camins A.

J Alzheimers Dis. 2018;62(3):1223-1240. doi: 10.3233/JAD-170672.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias